Abstract:Hepatocellular carcinoma (HCC) is one of the most heterogeneous malignant cancers with no effective targets and treatments. However, the molecular pathogenesis of HCC remains largely uncertain. The aims of our study were to find crucial genes involved in HCC through multidimensional methods and revealed potential molecular mechanisms. Here, we reported the gene expression profile GSE121248 findings from 70 HCC and 37 adjacent normal tissues, all of which had chronic hepatitis B virus (HBV) infection, we were seeking to identify the dysregulated pathways, crucial genes and therapeutic targets implicated in HBV-associated HCC. We found 164 differentially expressed genes (DEGs) (92 downregulated genes and 72 upregulated genes). Gene ontology (GO) analysis of DEGs revealed significant functional enrichment of mitotic nuclear division, cell division, and the epoxygenase P450 pathway. Kyoto Encyclopedia of Genes and Genomes (KEGG) analysis showed that the DEGs were mainly enriched in metabolism, cell cycle regulation and the p53 signaling pathway. The Mcode plugin was calculated to construct a module complex of DEGs, and the module was mainly enriched in cell cycle checkpoints, RHO GTPase effectors and cytochrome P450. Considering a weak contribution of each gene, gene set enrichment analysis (GSEA) was performed, revealing results consistent with those described above. Six crucial proteins were selected based on the degree of centrality, including NDC80, ESR1, ZWINT, NCAPG, ENO3 and CENPF. Real-time quantitative PCR analysis validated the six crucial genes had the same expression trend as predicted. Furthermore, the methylation data of The Cancer Genome Atlas (TCGA) with HCC showed that mRNA expression of crucial genes was negatively correlated with methylation levels of their promoter region. The overall survival reflected that high expression of NDC80, CENPF, ZWINT, and NCAPG significantly predicted poor prognosis, whereas ESR1 high expression exhibited a favorable prognosis. The identification of the crucial genes and pathways would contribute to the development of novel molecular targets and biomarker-driven treatments for HCC.

Identification of differential expression of genes in hepatocellular carcinoma by suppression subtractive hybridization combined cDNA microarray.

Identification of the typical miRNAs and target genes in hepatocellular carcinoma.

Identification Of Genes Differentially Expressed In Human Hepatocellular Carcinoma By A Modified Suppression Subtractive Hybridization Method

Genes Encoding Pir51, Beclin 1, RbAp48 and Aldolase B Are Up or Down-Regulated in Human Primary Hepatocellular Carcinoma.

Screening and Analysis of Differentially Expressed Genes in Human Hepatocellular Carcinoma Using Suppression Subtractive Hybridization

Identification of Hepatocellular Carcinoma-associated Hub Genes and Pathways by Integrated Microarray Analysis

Identification of genes in hepatocellular carcinoma induced by non-alcoholic fatty liver disease

Down-regulated Expression of Cytochrome P450 Related Genes Involved in Hepatocellular Carcinoma

Identification of Gene Expression Profiling in Hepatocellular Carcinoma Using Cdna Microarrays

Genes Expression Profiling of Peripheral Blood Cells of Patients with Hepatocellular Carcinoma

Exploration of Differential Expressed Genes Involved in the Development and Progression of Hepatocellular Carcinoma Using Oligomicroarray

Discovery and Analysis of Hepatocellular Carcinoma Genes Using Cdna Microarrays

Combined Use of Laser Capture Microdissection and Gene Microchip Technigues for Differential Expression Gene Screening in Hepatocellular Carcinoma

Identification of Crucial Genes Based on Expression Profiles of Hepatocellular Carcinomas by Bioinformatics Analysis.

Combination of Suppresion Subtractive Hybridization and Cdna Microarray for Identification of the Hepatic Stellate Cell Continual Activation Related Genes

Gene Expression Profiling Reveals Potential Biomarkers of Human Hepatocellular Carcinoma

Screening of Novel Hepatocellular Carcinoma-Associated Genes

Identification of prognosis-related genes in hepatocellular carcinoma based on bioinformatical analysis

Expression Profile Reveals Novel Prognostic Biomarkers in Hepatocellular Carcinoma.

Aberrant Gene Expression Profiles in Hepatocellular Carcinoma Detected by Microdissection

Expression Profiling Suggested a Regulatory Role of Liver-Enriched Transcription Factors in Human Hepatocellular Carcinoma.